HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead GlobeNewswire October 31, 2025 NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA's HB-400 program and certain of its assets related to […]